| EXACT SCIENCES |
| USA |
| Gesundheit |
| US30063P1057 / 590273 |
| EXK (Frankfurt) / EXAS (NASDAQ) |
| FRA:EXK, ETR:EXK, EXK:GR, NASDAQ:EXAS |
| - |
| https://www.exactsciences.. |
|
Exact Sciences Corp is a leading molecular diagnostics company specializing in cancer screening and diagnostic tests. Its flagship product, Cologuard, is a non-invasive stool-based DNA test designed to detect colorectal cancer and pre-cancer through ..
>Volltext.. |
| 17315.12 Mio. EUR |
| 18640.04 Mio. EUR |
| 2807.44 Mio. EUR |
| 56.98 Mio. EUR |
| -179.8 Mio. EUR |
| -0.96 EUR |
| 2191.66 Mio. EUR |
| 826.58 Mio. EUR |
| 424.91 Mio. EUR |
| 1.5 |
| 3.74% |
| 82.19% |
| - |
| - |
| - |
| - |
| EXACT SCIENCES |
| 01.04.26 |